Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

Specialists have used them against severe, repeat C. diff for over 10 years, and medical guidelines have recommended them for that use since 2017. But Feuerstadt notes that having FDA-approved C. diff ...

Study finds underutilization of fidaxomicin, a recommended treatment for C. diff infection, despite increased use in hospitals.

C. difficile spores are highly resistant to desiccation, chemicals and extreme temperature. Spores frequently contaminate the environment around patients with CDI, potentially persisting for ...

H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...

Prior to the announcement of the winners on 1st October, we look at Astellas' Clostridium difficile therapy Dificlir ... of Astellas Pharma's C. diff treatment Dificlir (fidaxomicin) for the ...

In general, strive to use antibiotics covering a spectrum no broader than necessary and narrow the antibiotic spectrum of treatment ... Mild Clostridium difficile infection (CDI; stool frequency ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...